Shine Investment Advisory Services’s ANI Pharmaceuticals ANIP Stock Holding History

Shine Investment Advisory Services’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1K	Hold	25	–	–	﹤0.01%	694
2020 Q2	$1K	Hold	25	–	–	﹤0.01%	704
2020 Q1	$1K	Hold	25	–	–	﹤0.01%	688
2019 Q4	$2K	Hold	25	–	–	﹤0.01%	701
2019 Q3	$2K	Hold	25	–	–	﹤0.01%	691
2019 Q2	$2K	Hold	25	–	–	﹤0.01%	657
2019 Q1	$2K	Hold	25	–	–	﹤0.01%	670
2018 Q4	$1K	Hold	25	–	–	﹤0.01%	660
2018 Q3	$1K	Hold	25	–	–	﹤0.01%	633
2018 Q2	$2K	Hold	25	–	–	﹤0.01%	634
2018 Q1	$1K	Hold	25	–	–	﹤0.01%	638
2017 Q4	$2K	Hold	25	–	–	﹤0.01%	632
2017 Q3	$1K	Hold	25	–	–	﹤0.01%	649
2017 Q2	$1K	Buy	+25	New	+$1.21K	﹤0.01%	641

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Shine Investment Advisory Services's ANIP Position: Q3 2020 in Review

Shine Investment Advisory Services held its ANI Pharmaceuticals (ANIP) position steady in Q3 2020 at 25 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #694.

Shine Investment Advisory Services first reported a position in ANIP in Q2 2017 and has held it in 14 quarters since. The position peaked at $2K in Q4 2019. 116 funds tracked by Wall St. Rank hold ANIP as of Q3 2020.

Shine Investment Advisory Services held 25 shares of ANI Pharmaceuticals worth $1K as of Q3 2020.
Shine Investment Advisory Services left its ANI Pharmaceuticals share count unchanged in Q3 2020.
ANI Pharmaceuticals made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #694 holding.
Shine Investment Advisory Services first reported a position in ANI Pharmaceuticals in Q2 2017 and has held it in 14 quarters since.
Shine Investment Advisory Services's ANI Pharmaceuticals position peaked at $2K in Q4 2019.
116 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.